The International Terazosin Trial: A Multicentre Study of the Long-Term Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia

Publisher Website
Google Scholar
Abstract
Objective: To evaluate the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia (BPH). Methods: Thirty-three sites in 13 countries enrolled men with BPH who had an International Prostate Symptom Score (IPSS)